Back
dorma+kaba Holding AG Vs. Novo Nordisk AS Industry Stock Comparison
Buy
52
DRRKF
dorma+kaba Holding AG
Last Price:
$689.66
Seasonality Move:
12.35%
Sell
38
NVO
Novo Nordisk AS
Last Price:
$71.54
Seasonality Move:
1.2%
Buy
52
dorma+kaba Holding AG (DRRKF)
is a Buy
Is dorma+kaba Holding AG a Buy, Sell or Hold?
-
The current dorma+kaba Holding AG [DRRKF] share price is $689.66. The Score for DRRKF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
DRRKF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $70.73. The Score for NVO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRRKF Stock Price Chart
What is dorma+kaba Holding AG's stock price today?
-
The dorma+kaba Holding AG share price today is $689.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRRKF is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $70.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
DRRKF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 174.98 | Buy |
| Relative Strength Index (14 RSI): | 2.07 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (689.66 - 689.66) | Sell |
| Bollinger Bands (100): | (689.66 - 689.66) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 55.16 | Buy |
| Chaikin Money Flow: | -1275629 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DRRKF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 689.66 | Sell |
| 20-day SMA: | 689.66 | Sell |
| 50-day SMA: | 689.66 | Sell |
| 200-day SMA: | 705.63 | Sell |
| 8-day EMA: | 663.37 | Buy |
| 20-day EMA: | 501.91 | Buy |
| 50-day EMA: | 279.67 | Buy |
| 200-day EMA: | 84.07 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
dorma+kaba Holding AG Earnings Growth & DRRKF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.10 per share, an increase this year of $1.01 per share, and an increase next year of $0.54 per share.
dorma+kaba Holding AG Technical Analysis
| Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||